New

Blood Brain Barrier Technologies Market

2021

Blood Brain Barrier Technologies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies); Application (Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, and Others), and Geography

Publication Month: Oct 2021 | Report Code: TIPRE00021883 | No. of Pages: 157 | Category: Biotechnology | Status: Published

Market Insights

Blood Brain Barrier Technologies Market to Grow at a CAGR of 25.5% to reach US$ 5,101.94 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The blood brain barrier technologies market is projected to reach US$ 5,101.94 million by 2028 from US$ 1,041.05 million in 2021; it is estimated to register a CAGR of 25.5% from 2021 to 2028.

The brain is surrounded by protective fluid known as cerebrospinal fluid and a protective membrane called the meninges. Blood brain barrier is another protective element present between the brain's blood vessels, and the cells and other components that together make up brain tissue. The blood brain barrier protects the brain against disease-causing pathogens/toxins that may be present in the blood. It blocks the passage of foreign substances entering the brain tissue. It also blocks the passage of life-saving drugs used to treat neurodegeneration and neuroinflammation events. Thus, the technologies used to deliver drugs across blood brain barrier are different than the technologies used to deliver drugs to other body parts.

The blood brain barrier technologies market is segmented on the basis of technology, application, and geography. By geography, the market is further segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the globally leading market players.

Lucrative Regions for Blood Brain Barrier Technologies Market

Lucrative Regions for Blood Brain Barrier Technologies Market

Get more information on this report :



Market Insights

Growing Prevalence of Neurological Disorders Drives Blood Brain Barrier Technologies Market Growth

Neurological disorders such as epilepsy and seizures, Parkinson's disease, dementia, autism, Alzheimer's disease, brain tumors, and cerebral palsy affect the brain and nerves of the human body. The prevalence of neurological disorders is increasing in the US. According to the Centers for Disease Control and Prevention (CDC), Alzheimer's disease is one of the top 10 causes of death in the US. In 2020, Alzheimer's disease affected 5.8 million people in the country. Similarly, as per the estimates of the Parkinson's Foundation Prevalence Project, the US recorded 930,000 cases of Parkinson's Disease in 2020. Additionally, according to the Alzheimer's Association estimates, more than 6 million Americans have Alzheimer's disease, and the number is projected to reach ~13 million by 2050. Moreover, deaths due to Alzheimer's and dementia have increased by 16% in the US since the COVID-19 pandemic. On the other hand, deaths due to Alzheimer's have increased by 145% during 2000–2019.

Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. According to the World Health Organization (WHO), ~50 million people worldwide are suffering from epilepsy, making it one of the most common neurological diseases in the world. ~80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure free if they undergo proper diagnosis and treatment. Dementia is currently the seventh-leading cause of death among all diseases, and one of the leading causes of disability and addiction among elderly people worldwide. According to the WHO, more than 55 million people live with dementia worldwide, and there are ~10 million new cases every year. The condition is caused by a variety of diseases and injuries that primarily or secondarily affect the brain. Alzheimer's disease is the most common form of dementia and may contribute to 60–70% of cases. Thus, the growing prevalence of neurological disorders demands advanced blood-brain barrier technologies for the treatment, which is driving the market growth.

Increasing Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders Contribute to Blood Brain Barrier TechnologiesMarket Growth

Some neurologic disorders such as strokes, neuropathy, Alzheimer's disease, and Parkinson's disease are more common among the elderly populations, and their prevalence is increasing with the elevating life expectancies. According to the WHO, the population is aging rapidly worldwide. During 2015–2050, the world's population of age greater than 60 would nearly double, and its percentage would reach 22% from 12%. Mental and neurological disorders among older adults are likely to account for 6.6% of the total disability-adjusted life year (DALYs) for this age group. Also, as per the same source, ~15% of adults aged 60 and above have a mental disorder.

According to the CDC, Alzheimer's disease is the fifth leading cause of death in people with age 65 and above. Also, the number of people living with Alzheimer's disease doubles every five years. In 2020, Alzheimer's disease affected ~5.8 million Americans belonging to this age group, and by 2060, this number is expected to nearly triple to reach 14 million. The rate of mortalities caused by neurological disorders is also increasing. According to the Alzheimer's Association, 1 in 3 seniors dies with Alzheimer's disease or dementia every year in America.

Therefore, rising prevalence of age-associated neurological disorders is propelling the demand for the blood brain barrier technologies for better drug delivery.

Technology Insights

Based on technology, the global blood brain barrier technologies market is segmented into bispecific antibody RMT approach, trojan horse approach, increasing permeability, passive diffusion, and other noninvasive BBB technologies. In 2020, the increasing permeability segment held the largest share of the market. However, the reagents segment is expected to register the highest CAGR in the market during 2021–2028. Increased blood brain barrier (BBB) permeability is related with the remodeling of interendothelial junctional complex and gap formation between brain endothelial cells (paracellular pathway), and intensive pinocytotic vesicular transport between the apical and basal side of brain endothelial cells (transcellular path). The growth of the market for the increasing permeability segment can be attributed to the rising focus on research activities to treat many neurological and central nervous system disorders.

Application Insights

Based on application, the blood brain barrier technologies market is segmented into Alzheimer’s disease, epilepsy, Parkinson’s disease, multiple sclerosis, Hunter’s syndrome, brain cancer, and others. The Parkinson’s disease segment is expected to hold the largest market share in 2021.

Blood Brain Barrier Technologies Market, by Technology – 2021 and 2028

Blood Brain Barrier Technologies Market, by Technology – 2021 and 2028

Get more information on this report :



Strategic Insights

Product launches, and mergers and acquisitions are highly adopted strategies by the players operating in the global blood brain barrier technologies market. A few of the recent key market developments are listed below:

In December 2021, Eli Lilly acquired Prevail Therapeutics, a biotechnology company. Following the deal, Lilly plans to create a gene therapy program for people with neurodegenerative diseases, including Parkinson’s.

In October 2020, Bristol Myers Squibb announced the approval of ZEPOSIA (ozanimod) by Health Canada for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS) to decrease the frequency of clinical exacerbations.

According to a preliminary (yet to be peer-reviewed) research study by four Imperial College London academics, as well as other research-based evidence, the COVID-19 infection might cause neurological problems. This viewpoint developed during the first wave of the pandemic. The blood-brain barrier is a semipermeable membrane of endothelial cells that keeps the brain separated from the components and mechanisms of the rest of the body. Monocytes, a type of white blood cell, are activated as part of the body's defense mechanism when SARS-CoV-2 enters the bloodstream. To allow monocytes to cross the BBB, a complicated mechanism is activated. According to the same study, " blood-brain barrier facilitates the entry of infected and activated monocytes into the central nervous system, allowing the SARS-CoV-2 virus to pass through the loosened BBB. Hence, the rising demand for blood brain barrier technologies to detect neurological problems in COVID-19 patients is positively impacting the market growth.

Blood Brain Barrier Technologies – Market Segmentation

The global blood brain barrier technologies market is segmented into technology, application, and geography. In terms of technology, the market is segmented into bispecific antibody RMT approach, trojan horse approach, increasing permeability, passive diffusion, and other noninvasive BBB technologies. Based on application, the blood brain barrier technologies market is segmented into Alzheimer’s disease, epilepsy, Parkinson’s disease, multiple sclerosis, Hunter’s syndrome, brain cancer, and others.

Company Profiles

  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company.
  • Bristol-Myers Squibb Company
  • Pfizer, Inc.
  • Johnson and Johnson Services, Inc.
  • Fabre-Kramer Pharmaceuticals, Inc.
  • Bioasis Technologies Inc.
  • Abliva AB
  • JCR Pharmaceuticals Co., Ltd.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Blood Brain Barrier Technologies Market – By Technology

1.3.2 Global Blood Brain Barrier Technologies Market – By Application

1.3.3 Global Blood Brain Barrier Technologies Market– By Geography

2. Global Blood Brain Barrier Technologies Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Blood Brain Barrier Technologies Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Experts Opinion

5. Blood Brain Barrier Technologies Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Neurological Disorders

5.1.2 Increasing Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders

5.2 Market Restraints

5.2.1 Complications in Brain Medication Delivery

5.3 Market Opportunities

5.3.1 Large Number of Product Approvals and Launches

5.4 Future Trends

5.4.1 Nanoparticles for Brain Drug Delivery

5.5 Impact Analysis

6. Blood Brain Barrier Technologies Market– Global Analysis

6.1 Global Blood Brain Barrier Technologies Market Revenue Forecast and Analysis

6.2 Global Blood Brain Barrier Technologies Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Blood Brain Barrier Technologies Market Analysis and Forecast to 2028 – By Technology

7.1 Overview

7.2 Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)

7.3 Bispecific Antibody RMT Approach

7.3.1 Overview

7.3.2 Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Trojan Horse Approach

7.4.1 Overview

7.4.2 Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Increasing Permeability

7.5.1 Overview

7.5.2 Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Passive Diffusion

7.6.1 Overview

7.6.2 Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Other Non-Invasive BBB Technologies

7.7.1 Overview

7.7.2 Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8. Blood Brain Barrier Technologies Market Analysis – By Application

8.1 Overview

8.2 Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)

8.3 Alzheimer’s Disease

8.3.1 Overview

8.3.2 Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Epilepsy

8.4.1 Overview

8.4.2 Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Parkinson’s Disease

8.5.1 Overview

8.5.2 Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Multiple Sclerosis

8.6.1 Overview

8.6.2 Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Hunter’s Syndrome

8.7.1 Overview

8.7.2 Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Brain Cancer

8.8.1 Overview

8.8.2 Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Others

8.9.1 Overview

8.9.2 Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

9. Global Blood Brain Barrier Technologies Market – Geographic Analysis

9.1 North America: Blood Brain Barrier Technologies Market

9.1.1 Overview

9.1.2 North America: Blood Brain Barrier Technologies Market - Revenue and Forecast to 2028 (USD Million)

9.1.3 North America Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.4 North America Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5 North America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

9.1.5.1 US: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.1.1 US: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.1.2 US Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.5.1.3 US Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5.2 Canada: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.1 Canada: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.2 Canada Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.3 Canada Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.5.3 Mexico: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.3.1 Mexico: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.3.2 Mexico Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.1.5.3.3 Mexico Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.2 Europe: Blood Brain Barrier Technologies Market

9.2.1 Overview

9.2.2 Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.3 Europe: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.4 Europe: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.2.5 Europe: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028(%)

9.2.5.1 Germany: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.1.1 Germany: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.1.2 Germany: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.5.1.3 Germany: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.2.5.2 France: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.2.1 France: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.2.2 France: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.5.2.3 France: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.2.5.3 UK: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.3.1 UK: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.3.2 UK: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.5.3.3 UK: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.2.5.4 Italy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.4.1 Italy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.4.2 Italy: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.5.4.3 Italy: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.2.5.5 Spain: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.5.1 Spain: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.5.2 Spain: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.5.5.3 Spain: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.2.5.6 Rest of Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.6.1 Rest of Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.6.2 Rest of Europe: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.2.5.6.3 Rest of Europe: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3 Asia Pacific: Blood Brain Barrier Technologies Market

9.3.1 Overview

9.3.2 Asia Pacific: Blood Brain Barrier Technologies Market - Revenue and Forecast to 2028 (USD Million)

9.3.3 Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.4 Asia Pacific: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3.5 Asia Pacific: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

9.3.5.1 China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.1 China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.2 China: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.3 China: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3.5.2 Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.2.1 Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.2.2 Japan: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.5.2.3 Japan: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3.5.3 India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.1 India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.2 India: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.3 India: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3.5.4 South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.4.1 South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.4.2 South Korea: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.5.4.3 South Korea: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3.5.5 Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.5.1 Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.5.2 Australia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.5.5.3 Australia: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.3.5.6 Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.6.1 Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.6.2 Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

9.3.5.6.3 Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.4 Middle East and Africa: Blood Brain Barrier Technologies Market

9.4.1 Overview

9.4.2 Middle East and Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.3 Middle East and Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.4.4 Middle East and Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.4.5 Middle East and Africa: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

9.4.5.1 Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.1.1 Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.1.2 Saudi Arabia: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.4.5.1.3 Saudi Arabia: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.4.5.2 South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.2.1 South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.2.2 South Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.4.5.2.3 South Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.4.5.3 UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.3.1 UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.3.2 UAE: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.4.5.3.3 UAE: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.4.5.4 Rest of Middle East and Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.4.1 Rest of Middle East and Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.4.5.4.2 Rest of Middle East and Africa: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.4.5.4.3 Rest of Middle East and Africa: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.5 South and Central America: Blood Brain Barrier Technologies Market

9.5.1 Overview

9.5.2 South and Central America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.3 South and Central America: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.5.4 South and Central America: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.5.5 South and Central America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

9.5.5.1 Brazil: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.1.1 Brazil: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.1.2 Brazil: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.5.5.1.3 Brazil: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.5.5.2 Argentina: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.2.1 Argentina: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.2.2 Argentina: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.5.5.2.3 Argentina: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

9.5.5.3 Rest of South and Central America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.3.1 Rest of South and Central America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

9.5.5.3.2 Rest of South and Central America: Blood Brain Barrier Technologies Market, by Technology, 2019–2028 (USD Million)

9.5.5.3.3 Rest of South and Central America: Blood Brain Barrier Technologies Market, by Application, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Blood Brain Barrier Technologies Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Blood Brain Barrier Technologies Market– Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market, (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Eli Lilly and Company

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bristol-Myers Squibb Company

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Pfizer, Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Johnson and Johnson Services, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 FABRE-KRAMER PHARMACEUTICALS, INC.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Bioasis Technologies Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Abliva AB

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 JCR Pharmaceuticals Co., Ltd.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 2. North America Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 3. US Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 4. US Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Blood Brain Barrier Technologies Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. Mexico Blood Brain Barrier Technologies Market, by Technology -Revenue and Forecast to 2028 (USD Million)

Table 8. Mexico Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 9. Europe: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 10. Europe: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 11. Germany: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 12. Germany: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. France: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 14. France: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 15. UK: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 16. UK: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 17. Italy: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 18. Italy: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Spain: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 20. Spain: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Europe: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Europe: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 23. Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 24. Asia Pacific: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25. China: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 26. China: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 27. Japan: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 28. Japan: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 29. India: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 30. India: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. South Korea: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 32. South Korea: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 33. Australia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 34. Australia: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Asia Pacific: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 37. Middle East and Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 38. Middle East and Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 39. Saudi Arabia: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 40. Saudi Arabia: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 41. South Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 42. South Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 43. UAE: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 44. UAE: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 45. Rest of Middle East and Africa: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 46. Rest of Middle East and Africa: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 47. South and Central America: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 48. South and Central America: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 49. Brazil: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 50. Brazil: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 51. Argentina: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 52. Argentina: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 53. Rest of South and Central America: Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 54. Rest of South and Central America: Blood Brain Barrier Technologies Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 55. Organic Developments Done By Companies

Table 56. Inorganic Developments Done By Companies

Table 57. Glossary of Terms, Blood Brain Barrier Technologies Market

LIST OF FIGURES

Figure 1. Blood Brain Barrier Technologies Market Segmentation

Figure 2. Blood Brain Barrier Technologies Market Segmentation, By Region

Figure 3. Global Blood Brain Barrier Technologies Market Overview

Figure 4. Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Blood Brain Barrier Technologies Market, by Geography (US$ Million)

Figure 7. Global Blood Brain Barrier Technologies Market– Leading Country Markets (US$ Million)

Figure 8. Global Blood Brain Barrier Technologies Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe and PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. Global Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2020- 2028

Figure 15. Global Blood Brain Barrier Technologies Market – By Geography Forecast and Analysis – 2021- 2028

Figure 16. Market Positioning of Key Players in Global Blood Brain Barrier Technologies Market

Figure 17. Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)

Figure 18. Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)

Figure 24. Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. North America: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 32. North America Blood Brain Barrier Technologies Market Revenue and Forecast to 2028 (USD Million)

Figure 33. North America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 34. US: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Canada: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Mexico: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. Europe: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 38. Europe: Blood Brain Barrier Technologies Market Revenue and Forecast to 2028 (USD Million)

Figure 39. Europe: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 40. Germany: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. France: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. UK: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. Italy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 44. Spain: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 45. Rest of Europe: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 46. Asia Pacific: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 47. Asia Pacific: Blood Brain Barrier Technologies Market Revenue and Forecast to 2028 (USD Million)

Figure 48. Asia Pacific: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 49. China: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Japan: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. India: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 52. South Korea: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 53. Australia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 54. Rest of Asia Pacific: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. Middle East and Africa: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 56. Middle East and Africa: Blood Brain Barrier Technologies Market Revenue and Forecast to 2028 (USD Million)

Figure 57. Middle East and Africa: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 58. Saudi Arabia: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. South Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. UAE: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 61. Rest of Middle East and Africa: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 62. South and Central America: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)

Figure 63. South and Central America: Blood Brain Barrier Technologies Market Revenue and Forecast to 2028 (USD Million)

Figure 64. South and Central America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)

Figure 65. Brazil: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 66. Argentina: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. Rest of South and Central America: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)

Figure 68. Impact of COVID-19 Pandemic in North American Country Markets

Figure 69. Impact of COVID-19 Pandemic in European Country Markets

Figure 70. Impact of COVID-19 Pandemic on Asia Pacific Country Markets

Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 72. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 73. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Blood Brain Barrier Technologies Market

  1. Teva Pharmaceutical Industries Ltd.
  2. F. Hoffmann-La Roche Ltd.
  3. Eli Lilly and Company
  4. Bristol-Myers Squibb Company
  5. Pfizer, Inc.
  6. Johnson and Johnson Services, Inc.
  7. Fabre-Kramer Pharmaceuticals, Inc.
  8. Bioasis Technologies Inc.
  9. Abliva AB
  10. JCR Pharmaceuticals Co., Ltd.  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the blood brain barrier technologies market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.   
TIPRE00021883
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

The brain is surrounded by protective fluid known as cerebrospinal fluid and a protective membrane called the meninges. Similar another protective element is the blood brain barrier. this is a barrier between the brain's blood vessels and the cells and other components that together make up brain tissue. The blood brain barrier protects against disease-causing pathogens/toxins that may be present in the blood. It blocks the passage of foreign substances entering the brain tissue. It also blocks the passage of life-saving drugs used to treat neurodegeneration and neuroinflammation events. Thus, different technologies are used to deliver drugs across blood brain barrier.

Key factors driving the growth of the market are growing prevalence of neurological disorders and increasing geriatric population and neurological disorders associated with age are among the key factors driving the market.

Key players in the market are Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Eli Lilly and Company., Bristol-Myers Squibb Company, Pfizer, Inc., Johnson and Johnson Services, Inc., Fabre-Kramer Pharmaceuticals, Inc., Bioasis Technologies Inc., Abliva AB, and JCR Pharmaceuticals Co., Ltd. among others.

Nanoparticles for brain drug delivery is likely to act as trend the market growth in the comping years.

Increasing permeability is the most influencing segment growing in the blood brain barrier technologies market.

Large number of product approvals and launches are likely to fuel the market growth in the comping years.

Asia-Pacific is the lucrative for the blood brain barrier technologies market.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.